Securing funding is one of the most pressing challenges for early-stage companies. While equity funding often grabs the spotlight, grant funding for startups is a powerful but sometimes misunderstood alternative. Non-dilutive and often prestigious, grants can finance R&D, support collaborations, and validate your innovation. Yet they also demand time, reporting, and a tolerance for low success rates. In a session with our Funding Mastermind community, Funding Accelerator mentor David Arias of Strata outlined the grant landscape across the UK and Europe, sharing both the potential and the pitfalls. This blog brings together his insights with founder experiences to give a rounded view of how, when, and why to use grants.
Understanding grant funding for startups
Grants are public or institutional funds awarded to drive innovation, research, and collaboration. Unlike equity, they do not require you to give away ownership, and unlike loans, they do not have to be repaid. They are particularly useful for research-heavy projects, technology validation, and international partnerships.
However, not every grant is created equal. Some focus on basic research, others on late-stage commercialisation. The best outcomes come when a grant aligns closely with your roadmap and adds momentum rather than pulling you sideways.
Why founders pursue grants
Non-dilutive funding
Keep control of your cap table while still fuelling growth and development.
No repayment required
Grants do not sit on your balance sheet; your main duty is delivery and reporting.
Validation and credibility
Being selected by Innovate UK, Horizon Europe, or the EIC sends a strong signal to investors and customers.
Collaboration opportunities
Grants often require or encourage joint projects with universities, NHS bodies, or international partners.
Support for long-term R&D
They provide one of the few ways to fund projects in sectors like biotech or clean tech where ROI is measured in years.
The challenges that come with grants
Complex applications
Large grants often demand detailed submissions that take weeks to prepare and may need consultant input.
Reporting burdens
Quarterly or milestone-based reporting can tie up senior team members and slow progress if not well managed.
Risk of strategy drift
Chasing grants that don’t align with your roadmap can waste resources and dilute focus.
Disclosure of information
Applications and awards may require publishing sensitive details about your finances, IP, or partners.
Low success rates and cashflow strain
Many programmes have success rates below 10%, and some only release funds after spend, challenging early-stage cashflow.
Technology Readiness Levels and eligibility
Grant programmes are often tied to Technology Readiness Levels (TRLs). Early TRLs (basic research) can be funded at higher rates, while later TRLs (closer to market) receive lower rates under the assumption that private investors can support commercialisation. Mapping your true TRL is essential to targeting the right schemes.
Where to find grant opportunities
The UK has a strong non-dilutive funding ecosystem, and with association to Horizon Europe restored, UK companies can also access many EU programmes. The main schemes include:
Innovate UK Smart Grants — Up to £500,000 for individual projects or £1m for collaborations. Highly competitive with success rates as low as 3–5%. Applications are paper-based and assessed remotely, and all activity must be UK-based. Unfortunately, Innovate UK has paused Smart Grants during 2025 and 2026.
Challenge competitions and KTPs — Targeted calls on themes like AI, environment, or health. Competition is often lighter than Smart Grants. Knowledge Transfer Partnerships (KTPs) provide structured collaboration with research organisations.
Investor Partnerships — Blend Innovate UK grants with matched funding from approved investors. A powerful but not always consistently open option.
Eurostars — Co-funded by Horizon Europe and Innovate UK, supporting international collaboration. Applications are more approachable and success rates exceed 20%.
European Innovation Council (EIC) — Offers substantial grants and equity co-investment for science-based, IP-heavy innovations. Highly selective and best for research-driven startups.
Lessons from founder experiences
Kirsten from Uncommon compared two grants: one from NHS SBRI, which demanded weeks of reporting every quarter, and an Innovate UK scheme for underrepresented founders that was much more flexible and responsive. Her advice: always assess your capacity for reporting before applying.
Jo Tennant highlighted the stress of Innovate UK’s reimbursement model, which required proving spend before funds were released. This created cashflow strain that early-stage companies may struggle to absorb.
Dave Burrows of Damibu noted how reporting expectations can vary even within the same programme. Some grants paid largely upfront with minimal oversight, while others were heavily monitored. His tip: scrutinise payment schedules and reporting requirements before committing.
How investors view grant funding
Investor opinion is mixed. Deep-tech and healthtech investors often encourage grants, seeing them as effective non-dilutive runway. Software and consumer-focused investors can be sceptical, worrying about bureaucracy or distraction. Hatty Fawcett added that grants can sometimes delay product-market fit by cushioning companies from commercial pressure. The best approach is to show how grants complement rather than replace customer traction.
Key takeaways for founders
Use grants as a complement to equity, not a substitute for customer-driven growth.
Choose schemes that align tightly with your strategy to avoid wasted effort.
Be realistic about reporting and payment structures before committing.
Track commercial traction alongside grant milestones to reassure investors.
What next?
If you need support understanding grant funding why not join our next Funding Strategy Workshop to gain focus for your funding campaign. It’s free, interactive and online. Register here
FAQs: grant funding for startups
What is grant funding for startups?
Non-repayable funding from public or institutional sources to support innovation and R&D.
Do startups have to give up equity for grants?
No, grants are non-dilutive, you keep full ownership of your business.
What are the main risks of relying on grants?
Complex applications, heavy reporting, potential strategy drift, disclosure of sensitive information, and uncertain success rates.
Which grants are most relevant for UK startups?
Innovate UK Smart Grants (currently on hold), thematic challenge competitions, KTPs, Eurostars, and selected Horizon Europe and EIC programmes.
Do investors value grant funding?
Many do, especially in research-heavy sectors. Some worry about distraction, so it’s important to balance grants with visible market traction.
- How to Get Warm Introductions Without a Large Network – Sales Strategies for Founders - February 27, 2026
- Grants vs Equity Funding: What Assessors and Investors Really Look For - February 27, 2026
- Why Investors Hesitate Even When They Like the Business - February 26, 2026